Authors:
Chambers, TM
Holland, RE
Tudor, LR
Townsend, HGG
Cook, A
Bogdan, J
Lunn, DP
Hussey, S
Whitaker-Dowling, P
Youngner, JS
Sebring, RW
Penner, SJ
Stiegler, GL
Citation: Tm. Chambers et al., A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge, EQUINE V J, 33(7), 2001, pp. 630-636
Citation: Wd. Wilson et al., Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination, EQUINE V J, 33(7), 2001, pp. 644-650
Authors:
Lunn, DP
Hussey, S
Sebring, R
Rushlow, KE
Radecki, SV
Whitaker-Dowling, P
Youngner, JS
Chambers, TM
Holland, RE
Horohov, DW
Citation: Dp. Lunn et al., Safety, efficacy and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression, J AM VET ME, 218(6), 2001, pp. 900-906
Authors:
Gulick, RM
McAuliffe, V
Holden-Wiltse, J
Crumpacker, C
Liebes, L
Stein, DS
Meehan, P
Hussey, S
Forcht, J
Valentine, FT
Citation: Rm. Gulick et al., Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults - AIDS clinical trials group protocols 150 and 258, ANN INT MED, 130(6), 1999, pp. 510-514